Lara Sullivan is the founder of Pyxis Oncology. Pyxis Oncology has raised $326M in total funding. Latest round: IPO. Based in Cambridge, Massachusetts.
Lara Sullivan, M.D., is the Chief Executive Officer and Director of Pyxis Oncology, a biopharmaceutical company focused on antibody-drug conjugate (ADC) therapies for cancer. She has raised over $500M across her career and demonstrated extensive experience in biotech leadership and strategic scaling, including leading Pyxis through its NASDAQ IPO in 2021 and securing significant private financing.
Full founder directory · Investor directory · Company funding database · Fundraising library